Innovation Spotlight

ASPS Ventures Picks Winners!

Building on our past accelerator partnerships, ASPS Ventures now makes direct investments in early-stage medtech. In collaboration with venture capital partners, we aim to drive innovation through strategic funding, clinical insight and expert mentorship.

The companies featured here were selected and mentored through our MTI Accelerator partnerships—the majority of which advanced to the program’s final rounds and ranked among its top-performing companies.

Current Cohort

ASPS x MTI Accelerator

MEDCu is a biotech company that provides wound dressing products that are impregnated with copper oxide microparticles.

Entirety Biomedical develops and manufactures absorbable metal implants with optimized absorption profiles.

BRIJ Medical, a medical device maker introduces a new age of post-surgical and trauma incision care with proven technologies.

InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.

Regenyx Medical is redefining minimally invasive soft-tissue restoration with Lipogenyx™, a first-in-class, matrix-enhanced fat-grafting platform.

Previous Cohorts

Developer of medical devices designed to improve the lives of patients by minimizing risks associated with medical injections.

Avance Innovations is spearheading the development of the game-changing, patented microsurgical device, ORASIS.

Fasciotens helps with the open abdomen - increase the odds, reduce the risks.

Lattice Medical offers a 3D printed bioabsorbable medical device for breast reconstruction.

ReConstruct Bio is an innovative venture from Harvard’s Wyss Institute, redefining the fields of medical reconstruction and aesthetics.

4D EMR is a cloud-based practice management and electronic medical record system built specifically for plastic surgery and medical spa practices.

Cellulora is developing a novel cellulose-based material for soft tissue repair.

Fingy3D offers 3D-printed, body-powered finger prosthetics for amputations, which are customized, affordable, and designed to help users regain function.

ASPS x MTI Accelerator

ImmersiveTouch empowers clinicians with greater precision and consistency of care by accessing new insights from scans.

Newrotex develops innovative silk-based medical
solutions for the nervous system.

SUTUREGARD Medical is a company that develops devices to help with surgical wound closure, particularly for high-tension wounds and those prone to dehiscence.

Limax Biosciences is developing a strong and flexible hydrogel adhesive for wounds inside and outside the body.

Ad Vital is an AI-powered, all-in-one software platform designed for aesthetic medical practices to simplify daily operations

MTI Innovation Pipeline

Screening at Scale. Selecting the Best. Delivering Impact.

125+

Companies Screened Annually

5

Companies Selected Annually

Backed by ASPS clinical validation, mentorship and measurable outcomes.

150+

Patents Issued

100+

Peer-Reviewed Publications

23+

Products Launched

18

Cohort Companies

$160 M+

Total Capital Raised

50+

Animal Studies

2

Exits/Acquisitions

29+

Human Studies

$337,500+

MTI Competition Funding